Vortex Pharma Solution ApS: Financial statements 2023
CVR: 43009672
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Vortex Pharma Solution ApS (CVR 43009672) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -59,473 and a net result of DKK -294,926 compared with DKK 173,285 the year before. Equity in the 2023 report amounted to DKK -156,641. The company had 2 employees in the financial year.
- Gross Profit
- DKK -59,473
- Profit/Loss
- DKK -294,926
- Equity
- DKK -156,641
- Total Assets
- DKK 279,771
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -59 t. | -295 t. | -157 t. | 2 |
| 2022 | - | 319 t. | 173 t. | 213 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Vortex Pharma Solution ApS has published its annual report for 2022. Gross profit came to DKK 319,114, and the net result was DKK 173,285.
About Vortex Pharma Solution ApS
Vortex Pharma Solution ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2022. The company is registered under the industry Anden teknisk rådgivning. The management consists of Flavia Christina Ladwig Robles. The company is owned by Vortex Holdings ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 255,541 and a net result of DKK -34,561 compared with DKK 302,635 the year before. Equity in the 2025 report amounted to DKK 111,433.